STAR Act

The Bill 118 s 3275, also known as the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act, is a piece of legislation that aims to improve the lives of childhood cancer survivors and advance research efforts in the field of pediatric oncology.

The STAR Act was introduced in the Senate on March 22, 2018 by Senator Jack Reed of Rhode Island and was signed into law on June 5, 2018. The bill received bipartisan support and was co-sponsored by Senators Shelley Moore Capito, Johnny Isakson, and Chris Van Hollen.

The main provisions of the STAR Act include: 1. Improving childhood cancer research: The bill authorizes funding for the National Institutes of Health (NIH) to conduct research on childhood cancer, including studies on the long-term effects of treatment and ways to improve survivorship. 2. Enhancing pediatric cancer surveillance: The STAR Act requires the Centers for Disease Control and Prevention (CDC) to collect and maintain data on childhood cancer incidence, prevalence, and survival rates. This data will help researchers and policymakers better understand the impact of childhood cancer and develop targeted interventions. 3. Expanding access to childhood cancer treatments: The bill aims to increase access to innovative treatments for childhood cancer by supporting the development of new therapies and improving coordination between healthcare providers, researchers, and patients. 4. Supporting childhood cancer survivors: The STAR Act provides resources and support for childhood cancer survivors, including access to comprehensive care plans, survivorship programs, and mental health services. Overall, the STAR Act represents a significant step forward in the fight against childhood cancer by prioritizing research, improving access to care, and supporting survivors. The bill has been praised by advocacy groups, healthcare providers, and lawmakers for its comprehensive approach to addressing the unique needs of pediatric cancer patients and survivors.